Institutional & Family Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $125K | Hold |
1,350
| – | – | 0.02% | 172 |
|
|
2024
Q1 | $129K | Hold |
1,350
| – | – | 0.02% | 164 |
|
|
2023
Q4 | $103K | Hold |
1,350
| – | – | 0.02% | 186 |
|
|
2023
Q3 | $93.5K | Hold |
1,350
| – | – | 0.02% | 181 |
|
|
2023
Q2 | $127K | Hold |
1,350
| – | – | 0.02% | 161 |
|
|
2023
Q1 | $112K | Hold |
1,350
| – | – | 0.02% | 167 |
|
|
2022
Q4 | $101K | Hold |
1,350
| – | – | 0.02% | 171 |
|
|
2022
Q3 | $112K | Hold |
1,350
| – | – | 0.02% | 161 |
|
|
2022
Q2 | $128K | Hold |
1,350
| – | – | 0.02% | 156 |
|
|
2022
Q1 | $159K | Hold |
1,350
| – | – | 0.02% | 160 |
|
|
2021
Q4 | $175K | Hold |
1,350
| – | – | 0.03% | 163 |
|
|
2021
Q3 | $153K | Hold |
1,350
| – | – | 0.02% | 200 |
|
|
2021
Q2 | $140K | Hold |
1,350
| – | – | 0.02% | 202 |
|
|
2021
Q1 | $113K | Hold |
1,350
| – | – | 0.02% | 251 |
|
|
2020
Q4 | $123K | Hold |
1,350
| – | – | 0.03% | 231 |
|
|
2020
Q3 | $108K | Hold |
1,350
| – | – | 0.03% | 219 |
|
|
2020
Q2 | $93K | Hold |
1,350
| – | – | 0.02% | 243 |
|
|
2020
Q1 | $85K | Hold |
1,350
| – | – | 0.02% | 222 |
|
|
2019
Q4 | $105K | Hold |
1,350
| – | – | 0.02% | 223 |
|
|
2019
Q3 | $99K | Hold |
1,350
| – | – | 0.02% | 215 |
|
|
2019
Q2 | $83K | Hold |
1,350
| – | – | 0.02% | 250 |
|
|
2019
Q1 | $86K | Hold |
1,350
| – | – | 0.02% | 261 |
|
|
2018
Q4 | $69K | Hold |
1,350
| – | – | 0.02% | 279 |
|
|
2018
Q3 | $78K | Hold |
1,350
| – | – | 0.02% | 301 |
|
|
2018
Q2 | $66K | Hold |
1,350
| – | – | 0.01% | 324 |
|
|
2018
Q1 | $63K | Buy |
+1,350
| New | +$63K | 0.01% | 304 |
|